Chronic-urticaria specialists are scattered, leaving patients to figure it out on their own

A local chronic-urticaria patient broke out in a full-body relapse while tapering medication, having tried a range of Western drugs, Chinese medicine, probiotics and elimination diets with mixed results, and turned to an open community for guidance from others who had been through it. Many local chronic-skin-disease patients report long waits for public hospital allergy clinics and steep fees at private allergy specialists; after diagnosis, long-term medication (such as second-generation antihistamines and biologics) and lifestyle management (food-trigger screening, stress management) are largely left to patients to figure out by trial and error.

In the public system, Hong Kong patients with chronic urticaria, eczema and atopic dermatitis are split between dermatology and immunology, and multidisciplinary collaboration involving case-management nurses, dietitians and counsellors is not standard provision; private allergy specialists also lack fee and outcome disclosure standards, so patients face a heavy decision-making cost across different treatment options. This public–private fragmentation, compounded by information asymmetry, means chronic skin-disease management long relies on patients' own trial and error and on online community sharing, and the integration of local allergy-medicine services has yet to keep pace with population needs and the rise in environmental allergens.